|
(P1744) |
Effectiveness of wearable cardioverter defibrillators in ischemic cardiomyopathy: comparison of revascularisation procedures (PCI vs. CABG) |
|
|
V. Johnson, P. Grieshaber, S. Lehnhardt, A. Böning, C. W. Hamm, J. Schmitt (Gießen) |
|
(P1745) |
Wearable defibrillator in newly diagnosed heart failure: reduced rate of ICD implantation after improvement of left ventricular ejection fraction |
|
|
K. Krause, D. Stierle, A. Khan, H. Nägele (Hamburg) |
|
(P1746) |
Safety of Physician-Initiated Programming of Wearable Cardioverter-Defibrillator Detection Rates |
|
|
N. K. Wäßnig, M. Günther, S. Quick, R. H. Strasser, U. Speiser (Dresden) |
|
(P1747) |
A Real World Wearable Cardioverter Defibrillator Experience – what Are the Relevant Indications? |
|
|
T. Beiert, R. Malotki, N. Kraemer, F. Stöckigt, M. Linhart, G. Nickenig, J. W. Schrickel, R. Andrié (Bonn) |
|
(P1748) |
Real life experience with the treatment period (wear time) of the wearable cardioverter defibrillator (WCD) and follow-up including quality of life from a German single center cohort |
|
|
C. G. Schuhmann, M. Kubieniec, K. Lackermair, S. Kääb, R. Wakili, H. L. Estner, S. Fichtner (München) |
|
(P1749) |
Protecting Tachymyopathy Patients with the Wearable Cardioverter Defibrillator |
|
|
J. W. Erath, M. Vamos, A. Benz, A. Steidl, S. Hohnloser (Frankfurt am Main) |